K Pharma
4896.TTSE GROWTHPharmaceutical
Filed as K Pharma, Inc. (2023-11–2026-08)
Financials · Standalone
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | — | — | ¥1.0bn | — | — | — |
| Operating income | −¥916m | −¥836m | ¥366m | −¥354m | — | — |
| Ordinary income | −¥921m | −¥836m | ¥344m | −¥359m | −¥221m | −¥270m |
| Total assets | ¥2.9bn | ¥2.4bn | ¥3.3bn | ¥1.4bn | ¥206m | ¥57m |
| Net assets / equity | ¥1.3bn | ¥2.3bn | ¥3.1bn | ¥1.3bn | ¥179m | ¥8m |
| Operating cash flow | −¥918m | −¥984m | ¥454m | −¥363m | −¥196m | — |
| EPS (basic) | ¥-85.59 | ¥-72.94 | ¥25.42 | ¥-42.06 | ¥-30.09 | ¥-38,751.13 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 8
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 59 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 102 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 56 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 99 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 63 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 28 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 97 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 29 figures · EDINET |